OP
CRL icon

ORG Partners’s Charles River Laboratories CRL Stock Holding History

ORG Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.18K Sell
26
-13
-33% -$2.36K ﹤0.01% 1212
2025
Q3 		$6.1K Buy
39
+22
+129% +$3.49K ﹤0.01% 1085
2025
Q2 		$2.62K Buy
+17
New +$2.27K ﹤0.01% 1178

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

ORG Partners's CRL Position: Q4 2025 in Review

ORG Partners reduced its Charles River Laboratories (CRL) stake by 33% in Q4 2025, selling an estimated $2.36K and leaving 26 shares worth $5.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

ORG Partners first reported a position in CRL in Q2 2025 and has held it in 3 quarters since. The position peaked at $6.1K in Q3 2025. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • ORG Partners held 26 shares of Charles River Laboratories worth $5.18K as of Q4 2025.
  • ORG Partners sold 13 Charles River Laboratories shares in Q4 2025, an estimated $2.36K.
  • Charles River Laboratories made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1212 holding.
  • ORG Partners first reported a position in Charles River Laboratories in Q2 2025 and has held it in 3 quarters since.
  • ORG Partners's Charles River Laboratories position peaked at $6.1K in Q3 2025.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.